Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass

Anesthesiology

Volumn 120, Issue 3, 2014, Pages 590-600

  Sigaut, Stéphanie ^a   Tremey, Benjamin ^a   Ouattara, Alexandre ^b   Couturier, Roland ^c   Taberlet, Christian ^d   Grassin Delyle, Stanislas ^e   Dreyfus, Jean Francois ^a   Schlumberger, Sylvie ^a   Fischler, Marc ^a  

^a FOCH HOSPITAL   (France)

^b University Hospital   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

AGED; ARTICLE; BLEEDING; BLOOD; BLOOD CONSERVATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSFUSION;

AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLASMA; PLATELET TRANSFUSION; RETREATMENT; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84895441383     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182a443e8     Document Type: Article

References (35)

1. Levi M, Cromheecke ME, De Jonge E, Prins MH, De Mol BJ, Briët E, Büller HR: Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet 1999; 354:1940-7
2. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K: Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006; 20:230-41
3. Carless PA, Moxey AJ, Stokes BJ, Henry DA: Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-tohead trials. BMC Cardiovasc Disord 2005; 5:19
4. Brown JR, Birkmeyer NJ, OConnor GT: Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 115: 2801-13
5. Andersson L, Nilsoon IM, Colleen S, Granstrand B, Melander B: Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann N Y Acad Sci 1968; 146:642-58
6. Eriksson O, Kjellman H, Pilbrant A, Schannong M: Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 1974; 7:375-80
7. Pilbrant A, Schannong M, Vessman J: Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 1981; 20:65-72
8. Puigdellívol E, Carral ME, Moreno J, Plà-Delfina JM, Jané F: Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man. Int J Clin Pharmacol Ther Toxicol 1985; 23:298-301
9. Soslau G, Horrow J, Brodsky I: Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991; 38:113-9
10. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL: The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82:383-92
11. Nuttall GA, Gutierrez MC, Dewey JD, Johnson ME, Oyen LJ, Hanson AC, Oliver WC Jr: A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. J Cardiothorac Vasc Anesth 2008; 22:230-5
12. Karski JM, Dowd NP, Joiner R, Carroll J, Peniston C, Bailey K, Glynn MF, Teasdale SJ, Cheng DC: The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C). J Cardiothorac Vasc Anesth 1998; 12:642-6
13. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J: Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97:390-9
14. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators: A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-31
15. Reust DL, Reeves ST, Abernathy JH III, Dixon JA, Gaillard WF II, Mukherjee R, Koval CN, Stroud RE, Spinale FG: Temporally and regionally disparate differences in plasmin activity by tranexamic acid. Anesth Analg 2010; 110:694-701
16. Grassin-Delyle S, Tremey B, Abe E, Fischler M, Alvarez JC, Devillier P, Urien S: Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2013; Jul 23 [Epub ahead of print]
17. Royston D: Tranexamic acid in cardiac surgery: Is there a cause for concern? Crit Care 2010; 14:194
18. Berman M, Cardone D, Sharples L, Vuylsteke A, Klein A, Gerrard C, Dunning J, Tsui S, Jenkins D: Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: Review of 200 patients. Ann Thorac Surg 2010; 90:1432-6
19. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS: The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg 2010; 110:21-9
20. Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C: Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary openheart procedures: A retrospective analysis. Crit Care 2010; 14:R148
21. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M: High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110:350-3
22. Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F: High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93:148-54
23. Furtmüller R, Schlag MG, Berger M, Hopf R, Huck S, Sieghart W, Redl H: Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002; 301:168-73
24. Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA: Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012; 122:4654-66
25. Martin K, Wiesner G, Breuer T, Lange R, Tassani P: The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107:1783-90
26. Keyl C, Uhl R, Beyersdorf F, Stampf S, Lehane C, Wiesenack C, Trenk D: High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 2011; 39:e114-21
27. Martin K, Knorr J, Breuer T, Gertler R, Macguill M, Lange R, Tassani P, Wiesner G: Seizures after open heart surgery: Comparison of ?-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth 2011; 25:20-5
28. Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E: Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors. Can J Anaesth 2012; 59:6-13
29. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation: The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-65
30. Nardi K, Pelone G, Bartolo M, Di Ruzza MR, Storto M, Notte A, Grillea G, Colonnese C, Lembo G, Vecchione C: Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T. Ann Clin Biochem 2011; 48(Pt 6):575-8
31. Sirker A, Malik N, Bellamy M, Laffan MA: Acute myocardial infarction following tranexamic acid use in a low cardiovascular risk setting. Br J Haematol 2008; 141:907-8
32. Sundström A, Seaman H, Kieler H, Alfredsson L: The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research Database. BJOG 2009; 116:91-7
33. Karkouti K, OFarrell R, Yau TM, Beattie WS; Reducing Bleeding in Cardiac Surgery Research Group: Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth 2006; 53:781-94
34. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA II, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S: Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:S27-86
35. Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P, Utley M: The Papworth Bleeding Risk Score: A stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011; 39:924-30